Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

NCT00398073 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Intraocular Melanoma
Melanoma (Skin)

Interventions

BIOLOGICAL: mouse gp100 plasmid DNA vaccine
DEVICE: The Dermal PowderMed® devices
OTHER: intramuscularly (IM injection)

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]